ONCY ▲ +1.5% - Oncolytics Biotech Inc.
$ONCY - Oncolytics Biotech® Reports Accelerating Enrollment in Randomized REO 033 RAS-Mutant, MSS Colorectal Cancer Study
28-SEP-2026 09:30 AM ET
Share this post
More filings for $ONCY
View full $ONCY filing history →💬 Comments
Loading comments…
Leave a comment
